Revati J. Tatake

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

C M D'Urso, Z G Wang, Yan Cao et al. · Journal of Clinical Investigation · 1991 · 310 citations · Full text

Histocompatibility, Immunogenetics, Hla Immunogenetics +12

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

Revati J. Tatake, Margaret M. O’Neill, Charles A. Kennedy et al. · Biochemical and Biophysical Research Communications · 2008 · 154 citations

Medicine, Receptor Tyrosine Kinase, Mechanism Of Action +4

A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy

Masaaki Hayashi, Kyoko Imanaka‐Yoshida, Toshimichi Yoshida et al. · Nature Medicine · 2005 · 97 citations

Protein Quality Control, Heart Failure, Mitophagy +9

MEK5 is Activated by Shear Stress, Activates ERK5 and Induces KLF4 to Modulate TNF Responses in Human Dermal Microvascular Endothelial Cells

Paul Clark, Todd Jensen, Martin S. Kluger et al. · Microcirculation · 2010 · 74 citations · Full text

Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.

Michele Maio, Maresa Altomonte, Revati J. Tatake et al. · Journal of Clinical Investigation · 1991 · 66 citations · Full text

Histocompatibility, Hla Immunogenetics, Immunology +19